Kazal Type Serine Protease Inhibitor Domain Containing Protein 1 (KAZALD1) Antibody

Background

KAZALD1, also known as Kazal-type serine peptidase inhibitor domain 1, is a protein encoded by the KAZALD1 gene in humans. This protein belongs to the Kazal family of serine protease inhibitors, which are characterized by their ability to inhibit serine proteases, enzymes that play critical roles in various physiological processes including digestion, coagulation, immune response, and cellular signaling. The Kazal family is named after Alexander Kazal, who first described these types of inhibitors. KAZALD1 has attracted interest in scientific research due to its potential role in various biological processes and diseases. Its expression has been observed in different tissues, suggesting that it may have diverse functions. Research into KAZALD1 is ongoing, with studies exploring its role in cancer, inflammation, and other conditions. Understanding KAZALD1's structure and function can provide insights into its biological significance and potential therapeutic applications.